Unicycive Therapeutics (UNCY)

• Market cap: $196M
• 1 day: 1.17%
• 5 days: 5.44%
• 1 month: 8.85%
• 3 months: 20.16%
• 6 months: 74.55%
• Year to date: 33.62%
• 1 year: 19.23%
• 5 years: -86.75%
• 10 years: -86.75%
• Sector: Healthcare
• Industry: Biotechnology

About: Unicycive Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and commercializing therapies to address unmet medical needs, with a primary focus on kidney disease. The company is advancing two key product candidates: oxylanthanum carbonate (OLC), a phosphate binder for the treatment of hyperphosphatemia in chronic kidney disease patients on dialysis, and UNI-494, a drug candidate for the treatment of acute kidney injury.

Employees: 22